Share of cumulative clinical trial starts worldwide 2000-2018, by cancer indication

This statistic depicts the percentage of cumulative clinical trials started globally between 2000 and 2018, by cancer type. During these years, lung cancer-related clinical trials made up 3.1 percent of all clinical trials, followed closely by breast cancer with three percent of clinical trials started.

Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

November 2019

Region

Worldwide

Survey time period

2000 to 2018

Supplementary notes

* Trials looking at two or more indications are repeat counted for each indication.
** “Other indications” includes those indications not shown as well as tumor-agnostic trials that do not specify any tumor type; if a trial lists both specified and unspecified tumor types, then it would be counted under each of the specified tumor types.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Cancer worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.